Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 11, 2023

BUY
$36.12 - $41.79 $25,789 - $29,838
714 Added 10.98%
7,216 $264,000
Q4 2022

Jan 23, 2023

BUY
$41.75 - $54.5 $44,505 - $58,097
1,066 Added 19.61%
6,502 $0
Q3 2022

Oct 21, 2022

SELL
$43.76 - $53.42 $87,520 - $106,840
-2,000 Reduced 26.9%
5,436 $238,000
Q2 2022

Jul 28, 2022

BUY
$46.53 - $55.17 $13,400 - $15,888
288 Added 4.03%
7,436 $390,000
Q1 2022

Apr 20, 2022

SELL
$45.75 - $56.69 $73,200 - $90,704
-1,600 Reduced 18.29%
7,148 $370,000
Q4 2021

Jan 18, 2022

SELL
$41.32 - $61.25 $15,495 - $22,968
-375 Reduced 4.11%
8,748 $517,000
Q3 2021

Oct 27, 2021

SELL
$39.25 - $50.42 $93,218 - $119,747
-2,375 Reduced 20.66%
9,123 $392,000
Q2 2021

Aug 04, 2021

SELL
$35.91 - $40.68 $50,022 - $56,667
-1,393 Reduced 10.81%
11,498 $450,000
Q1 2021

Apr 09, 2021

BUY
$33.49 - $37.77 $91,126 - $102,772
2,721 Added 26.76%
12,891 $467,000
Q4 2020

Jan 22, 2021

BUY
$33.47 - $42.56 $53,552 - $68,096
1,600 Added 18.67%
10,170 $374,000
Q3 2020

Oct 21, 2020

SELL
$31.75 - $37.25 $9,652 - $11,324
-304 Reduced 3.43%
8,570 $315,000
Q2 2020

Jul 15, 2020

BUY
$30.12 - $36.54 $162,648 - $197,316
5,400 Added 155.44%
8,874 $291,000
Q3 2019

Oct 29, 2019

SELL
$32.49 - $42.13 $39,345 - $51,019
-1,211 Reduced 25.85%
3,474 $125,000
Q2 2019

Jul 16, 2019

BUY
$36.98 - $41.52 $173,251 - $194,521
4,685 New
4,685 $203,000
Q1 2019

Apr 04, 2019

SELL
$37.5 - $41.2 $132,187 - $145,230
-3,525 Closed
0 $0
Q3 2018

Oct 12, 2018

BUY
$34.47 - $41.81 $121,506 - $147,380
3,525 New
3,525 $155,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Selective Wealth Management, Inc. Portfolio

Follow Selective Wealth Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Selective Wealth Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Selective Wealth Management, Inc. with notifications on news.